Beschreibung

vor 7 Jahren

Dr. Ganesh Raghu discusses the highly anticipated results of the
WRAP-IPF trial, borne out of debate surrounding the role of
GER in the pathogenesis and progression of IPF, and conflicting
findings from retrospective studies of antacid therapies on
survival and disease progression.


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15